Shen D C, Shieh S M, Fuh M M, Wu D A, Chen Y D, Reaven G M
Department of Medicine, Stanford University School of Medicine, California 94304.
J Clin Endocrinol Metab. 1988 Mar;66(3):580-3. doi: 10.1210/jcem-66-3-580.
Plasma glucose and insulin responses to a glucose challenge and insulin-stimulated glucose uptake were measured in 24 age-, weight-, and sex-matched Chinese men (8 with normal blood pressure, 8 with untreated hypertension, and 8 patients with hypertension treated with thiazide and beta-adrenergic antagonist drugs). Plasma glucose and insulin responses were determined by measuring plasma glucose and insulin concentrations before and at 30-min intervals for 2 h after a 75-g oral glucose dose. Insulin-stimulated glucose uptake was estimated by measuring the steady state plasma glucose (SSPG) and insulin (SSPI) concentrations achieved during the last 60 min of a 180-min continuous infusion of somatostatin, insulin, and glucose (insulin suppression test). Under these conditions endogenous insulin secretion was suppressed, and similar SSPI concentrations were achieved in all men; thus, the differences in the resultant SSPG concentrations allowed direct comparison of insulin's ability to stimulate disposal of an identical glucose load in different individuals. The results indicated that the men with hypertension, whether treated or untreated, had significantly elevated plasma glucose (P less than 0.001) and insulin (P less than 0.001) responses to the oral glucose dose compared to the normal men. Mean (+/- SE) SSPG concentrations were also higher (P less than 0.001) in the men with either untreated hypertension [219 +/- 9 mg/dL (12.2 +/- 0.5 mmol/L)] or treated hypertension [211 +/- 18 mg/dL (11.7 +/- 1.0 mmol/L)] than in the normal men [134 +/- 13 mg/dL (7.4 +/- 0.7 mmol/L)]. Since the mean SSPI concentrations were similar in the 3 groups [approximately 70 microU/mL (502 pmol/L)], insulin was less effective in promoting glucose disposal in both groups with hypertension. These results document the fact that patients with hypertension, whether treated or untreated, are insulin resistant, hyperglycemic, and hyperinsulinemic compared to a well-matched control group.
对24名年龄、体重和性别匹配的中国男性(8名血压正常者、8名未经治疗的高血压患者以及8名接受噻嗪类药物和β-肾上腺素能拮抗剂治疗的高血压患者)进行了血浆葡萄糖和胰岛素对葡萄糖激发试验的反应以及胰岛素刺激的葡萄糖摄取的测定。通过在口服75克葡萄糖后,测量给药前以及之后2小时内每隔30分钟的血浆葡萄糖和胰岛素浓度,来确定血浆葡萄糖和胰岛素反应。通过测量在180分钟持续输注生长抑素、胰岛素和葡萄糖(胰岛素抑制试验)的最后60分钟内达到的稳态血浆葡萄糖(SSPG)和胰岛素(SSPI)浓度,来估计胰岛素刺激的葡萄糖摄取。在这些条件下,内源性胰岛素分泌受到抑制,所有男性达到相似的SSPI浓度;因此,所得SSPG浓度的差异使得能够直接比较胰岛素在不同个体中刺激处理相同葡萄糖负荷的能力。结果表明,与正常男性相比,患有高血压的男性,无论是否接受治疗,对口服葡萄糖剂量的血浆葡萄糖(P<0.001)和胰岛素(P<0.001)反应均显著升高。未经治疗的高血压男性[219±9mg/dL(12.2±0.5mmol/L)]或接受治疗的高血压男性[211±18mg/dL(11.7±1.0mmol/L)]的平均(±SE)SSPG浓度也高于正常男性[134±13mg/dL(7.4±0.7mmol/L)](P<0.001)。由于三组的平均SSPI浓度相似[约70μU/mL(502pmol/L)],胰岛素在促进两组高血压患者的葡萄糖处置方面效果较差。这些结果证明了这样一个事实,即与匹配良好的对照组相比,患有高血压的患者,无论是否接受治疗,均存在胰岛素抵抗、高血糖和高胰岛素血症。